Novo Nordisk discloses clinical trials data breach

Novo Nordisk, the Danish pharmaceutical giant and leading global insulin manufacturer, has disclosed a data breach affecting patient information from clinical trials.

This article has been indexed from CyberMaterial

Read the original article: